ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993

Justice Department Clears SWOG Study Of Breast Cancer Treatment Costs

November 17, 1995